Target renal damage: The microvascular associations of increased aortic stiffness in patients with COPD

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  John, Michelle ^a   Hussain, Samia ^a   Prayle, Andrew ^a   Simms, Rebecca ^a   Cockcroft, John R ^b   Bolton, Charlotte E ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Arterial stiffness; Biomarkers; Haemodynamics; Kidney; Microvascular; Renal

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE;

AGED; ALBUMINURIA; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CREATININE URINE LEVEL; FEMALE; HUMAN; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MICROVASCULATURE; PROGNOSIS; PULSATILE FLOW; PULSE WAVE; SPIROMETRY; URINALYSIS; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; URINE; METHODOLOGY;

ALBUMINURIA; BIOLOGICAL MARKERS; CREATININE; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MICROVESSELS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VASCULAR STIFFNESS;

EID: 84874502314     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-31     Document Type: Article

References (44)

1. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA: Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2006, 62: 411-415. 2007
2. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, Wilkinson IB, Cockcroft JR, Shale DJ: Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007, 175: 1259-1265. 10.1164/rccm.200701-067OC.
3. Maclay JD, McAllister DA, Mills NL, Paterson FP, Ludlam CA, Drost EM, Newby DE, Macnee W: Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009, 180: 513-520. 10.1164/rccm.200903-0414OC.
4. Maclay JD, McAllister DA, Johnston S, Raftis J, McGuinnes C, Deans A, Newby DE, Mills NL, MacNee W: Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax. 2011, 66: 769-774. 10.1136/thx.2010.157529.
5. Sabit R, Bolton CE, Fraser AG, Edwards JM, Edwards PH, Ionescu AA, Cockcroft JR, Shale DJ: Sub-clinical left and right ventricular dysfunction in patients with COPD. Respir Med. 2010, 104: 1171-1178. 10.1016/j.rmed.2010.01.020.
6. Rutten FH, Vonken EJ, Cramer MJ, Moons KG, Velthuis BB, Prakken NH, Lammers JW, Grobbee DE, Mali WP, Hoes AW: Cardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary disease. Am Heart J. 2008, 156: 506-512. 10.1016/j.ahj.2008.04.021.
7. Mitchell GF: Effects of central arterial aging on the structure and function of the peripheral vasculature: implications for end-organ damage. J Appl Physiol. 2008, 105: 1652-1660. 10.1152/japplphysiol.90549.2008.
8. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P: N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA. 2005, 293: 1609-1616. 10.1001/jama.293.13.1609.
9. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE: Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002, 106: 1777-1782. 10.1161/01.CIR.0000031732.78052.81.
10. Mule G, Cottone S, Cusimano P, Riccobene R, Palermo A, Geraci C, Nardi E, Bellavia T, Foraci AC, Cerasola G: The association of microalbuminuria with aortic stiffness is independent of C-reactive protein in essential hypertension. Am J Hypertens. 2009, 22: 1041-1047. 10.1038/ajh.2009.132.
11. Liu CS, Pi-Sunyer FX, Li CI, Davidson LE, Li TC, Chen W, Lin CC, Huang CY, Lin WY: Albuminuria is strongly associated with arterial stiffness, especially in diabetic or hypertensive subjects-a population-based study (Taichung Community Health Study, TCHS). Atherosclerosis. 2010, 211: 315-321. 10.1016/j.atherosclerosis.2010.02.015.
12. Smith A, Karalliedde J, De Angelis L, Goldsmith D, Viberti G: Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes. J Am Soc Nephrol. 2005, 16: 1069-1075. 10.1681/ASN.2004090769.
13. Kim BJ, Lee HA, Kim NH, Kim MW, Kim BS, Kang JH: The association of albuminuria, arterial stiffness, and blood pressure status in nondiabetic, nonhypertensive individuals. J Hypertens. 2011, 29: 2091-2098. 10.1097/HJH.0b013e32834b5627.
14. Hermans MM, Henry R, Dekker JM, Kooman JP, Kostense PJ, Nijpels G, Heine RJ, Stehouwer CD: Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol. 2007, 18: 1942-1952. 10.1681/ASN.2006111217.
15. Incalzi RA, Corsonello A, Pedone C, Battaglia S, Paglino G, Bellia V: Chronic renal failure: a neglected comorbidity of COPD. Chest. 2010, 137: 831-837. 10.1378/chest.09-1710.
16. Gjerde B, Bakke PS, Ueland T, Hardie JA, Eagan TM: The prevalence of undiagnosed renal failure in a cohort of COPD patients in western Norway. Respir Med. 2012, 106: 361-366. 10.1016/j.rmed.2011.10.004.
17. Casanova C, de Torres JP, Navarro J, Aguirre-Jaime A, Toledo P, Cordoba E, Baz R, Celli BR: Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010, 182: 1004-1010. 10.1164/rccm.201003-0360OC.
18. Global Strategy for the Diagnosis: Management and Prevention of Chronic Obstructive Pulmonary Disease, 2011. 2012, 1-90.
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999, 130: 461-470.
20. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.
21. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N: Development and first validation of the COPD Assessment Test. Eur Respir J. 2009, 34: 648-654. 10.1183/09031936.00102509.
22. Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992, 145: 1321-1327.
23. Leoncini G, Ratto E, Viazzi F, Parodi A, Falqui V, Conti N, Tomolillo C, Deferrari G, Pontremoli R: Improving cardiovascular risk stratification: the case for redefining microalbuminuria. J Nephrol. 2007, 20 (Suppl 12): S51-S55.
24. Ratto E, Leoncini G, Viazzi F, Vaccaro V, Parodi A, Falqui V, Bezante GP, Tomolillo C, Deferrari G, Pontremoli R: Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised?. Am J Hypertens. 2006, 19: 728-734. 10.1016/j.amjhyper.2005.12.018. discussion 735-6
25. KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Straification. 2012, http://www.kidney.org/professionals/KDOQI/guidelines_ckd/toc.htm ,
26. Grubb A, Nyman U, Bjork J, Lindstrom V, Rippe B, Sterner G, Christensson A: Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem. 2005, 51: 1420-1431. 10.1373/clinchem.2005.051557.
27. Stevens LA, Zhang Y, Schmid CH: Evaluating the performance of equations for estimating glomerular filtration rate. J Nephrol. 2008, 21: 797-807.
28. Lewko B, Stepinski J: Hyperglycemia and mechanical stress: targeting the renal podocyte. J Cell Physiol. 2009, 221: 288-295. 10.1002/jcp.21856.
29. Dworkin LD, Benstein JA: Impact of antihypertensive therapy on progressive kidney damage. Am J Hypertens. 1989, 2: 162S-172S.
30. Nakamori A, Ando Y, Matsuda H, Kimura T, Minami H, Imai E, Yura T: Influence of proteinuria on renal Doppler sonographic measurements in chronic kidney disease and in diabetes mellitus. J Clin Ultrasound. 2011, 39: 506-511. 10.1002/jcu.20822.
31. Hamano K, Nitta A, Ohtake T, Kobayashi S: Associations of renal vascular resistance with albuminuria and other macroangiopathy in type 2 diabetic patients. Diabetes Care. 2008, 31: 1853-1857. 10.2337/dc08-0168.
32. Hashimoto J, Ito S: Central pulse pressure and aortic stiffness determine renal hemodynamics: pathophysiological implication for microalbuminuria in hypertension. Hypertension. 2011, 58: 839-846. 10.1161/HYPERTENSIONAHA.111.177469.
33. Fesler P, Safar ME, du Cailar G, Ribstein J, Mimran A: Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J Hypertens. 2007, 25: 1915-1920. 10.1097/HJH.0b013e3281fbd15e.
34. Wang TJ, Evans JC, Meigs JB, Rifai N, Fox CS, D'Agostino RB, Levy D, Vasan RS, Macdonald J: Am J Kidney Dis. 2006, 48 (712-9): 1370-1376.
35. Gan WQ, Man SF, Senthilselvan A, Sin DD: Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004, 59: 574-580. 10.1136/thx.2003.019588.
36. Eickhoff P, Valipour A, Kiss D, Schreder M, Cekici L, Geyer K, Kohansal R, Burghuber OC: Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008, 178: 1211-1218. 10.1164/rccm.200709-1412OC.
37. Andreas S, Anker SD, Scanlon PD, Somers VK: Neurohumoral activation as a link to systemic manifestations of chronic lung disease. Chest. 2005, 128: 3618-3624. 10.1378/chest.128.5.3618.
38. Hansen JM, Olsen NV, Feldt-Rasmussen B, Kanstrup IL, Dechaux M, Dubray C, Richalet JP: Albuminuria and overall capillary permeability of albumin in acute altitude hypoxia. J Appl Physiol. 1994, 76: 1922-1927.
39. Short PM, Lipworth SI, Elder DH, Schembri S, Lipworth BJ: Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study. BMJ. 2011, 342: d2549-10.1136/bmj.d2549.
40. Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD: Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol. 2006, 17: 537-545. 10.1681/ASN.2005080834.
41. Amann K, Wanner C, Ritz E: Cross-talk between the kidney and the cardiovascular system. J Am Soc Nephrol. 2006, 17: 2112-2119. 10.1681/ASN.2006030204.
42. Wilkinson IB, McEniery CM, Cockcroft JR: Arteriosclerosis and atherosclerosis: guilty by association. Hypertension. 2009, 54: 1213-1215. 10.1161/HYPERTENSIONAHA.109.142612.
43. Rosenson RS, Fioretto P, Dodson PM: Does microvascular disease predict macrovascular events in type 2 diabetes?. Atherosclerosis. 2011, 218: 13-18. 10.1016/j.atherosclerosis.2011.06.029.
44. Elving LD, Bakkeren JA, Jansen MJ, de Kat Angelino CM, de Nobel E, van Munster PJ: Screening for microalbuminuria in patients with diabetes mellitus: frozen storage of urine samples decreases their albumin content. Clin Chem. 1989, 35: 308-310.